tiprankstipranks
Bright Minds Biosciences (TSE:DRUG)
CNQX:DRUG
Holding TSE:DRUG?
Track your performance easily

Bright Minds Biosciences (DRUG) Cash flow

53 Followers

Bright Minds Biosciences Cash Flow

TSE:DRUG's free cash flow for Q4 2023 was C$―. For the 2023 fiscal year, TSE:DRUG's free cash flow was decreased by C$6.56M and operating cash flow was C$―. See a summary of the company’s cash flow.
Cash Flow
TTM
Sep 23Sep 22Sep 21Sep 20
Operating Cash Flow
C$ -5.53MC$ -7.02MC$ -13.59MC$ -7.32MC$ -288.39K
Investing Cash Flow
-----
Financing Cash Flow
C$ 2.27MC$ 2.19MC$ 5.20MC$ 26.06MC$ 1.01M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
C$ 19.85MC$ 6.75MC$ 11.37MC$ 19.76MC$ 799.93K
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
-----
Issuance Of Capital Stock
C$ 1.22MC$ 1.22MC$ 4.03MC$ 27.74MC$ 1.01M
Issuance Of Debt
-C$ -86.11KC$ -7.16K--
Repayment Of Debt
C$ -21.49KC$ -86.11KC$ -7.16K--
Free Cash Flow
C$ -5.53MC$ -7.02MC$ -13.59MC$ -7.32MC$ -288.39K
Domestic Sales
-----
Foreign Sales
-----
Currency in CAD

Bright Minds Biosciences Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis